CO2 Solution Announces Significant Enzymatic Carbon Capture Results and New Patent Applications
New results achieved with proprietary, patented enzyme show potential to dramatically lower the cost of large-scale CO2 capture Trading symbol: CST Outstanding shares: 50,261,136
The testing was carried out in collaboration with CO2 Solution’s process partner, Procede Group B.V., a leading chemical engineering firm. The Co-Founder of Procede, Dr.
CO2 Solution is also pleased to announce that it has filed three new patent applications in the field of enzymatic carbon capture which it believes will have significant value by further expanding the range of application of its enzymatic technology in packed columns and other scrubbing systems. Amongst the patent applications, is a new enzyme delivery method which the Company believes will provide for further improvements in utilizing carbonic anhydrase for efficient CO2 capture.
Commenting on the results achieved and the new patent applications, Mr.
About CO2 Solution
CO2 Solution’s technology platform is protected by several North American and European patents, including the use of carbonic anhydrase for CO2 capture and release in a packed column system. News releases and additional information can be found at www.co2solution.com
The TSX Venture Exchange has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
SOURCE CO2 SOLUTION INC.